Anti-Tumor Necrosis Factor Treatment does not decrease the Risk of Type 2 Diabetes in Patients with Inflammatory Bowel Disease

Marie Villumsen*, Gry Poulsen, Nynne Nyboe Andersen, Mikael Andersson, Tine Jess, Kristine Højgaard Allin

*Kontaktforfatter

Publikation: Bidrag til tidsskriftLetterpeer review

1 Citationer (Scopus)
29 Downloads (Pure)

Citationsformater